Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.
Di Federico A, Mosca M, Pagani R, Carloni R, Frega G, De Giglio A, Rizzo A, Ricci D, Tavolari S, Di Marco M, Palloni A, Brandi G. Di Federico A, et al. Among authors: mosca m. Cancers (Basel). 2022 May 14;14(10):2429. doi: 10.3390/cancers14102429. Cancers (Basel). 2022. PMID: 35626033 Free PMC article. Review.
Non-small-cell lung cancer: how to manage RET-positive disease.
Andrini E, Mosca M, Galvani L, Sperandi F, Ricciuti B, Metro G, Lamberti G. Andrini E, et al. Among authors: mosca m. Drugs Context. 2022 Jul 11;11:2022-1-5. doi: 10.7573/dic.2022-1-5. eCollection 2022. Drugs Context. 2022. PMID: 35912003 Free PMC article. Review.
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease.
Metro G, De Giglio A, Ricciuti B, Siringo M, Marinelli D, Gelibter A, Pecci F, Berardi R, Cantini L, Di Federico A, Andrini E, Mosca M, Lamberti G, Brambilla M, Mountzios G. Metro G, et al. Among authors: mosca m. Drugs Context. 2022 Jul 29;11:2022-3-9. doi: 10.7573/dic.2022-3-9. eCollection 2022. Drugs Context. 2022. PMID: 35975031 Free PMC article. Review.
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.
Rizzo A, Ricci AD, Tober N, Nigro MC, Mosca M, Palloni A, Abbati F, Frega G, DE Lorenzo S, Tavolari S, Brandi G. Rizzo A, et al. Among authors: mosca m. Anticancer Res. 2020 Jun;40(6):3013-3030. doi: 10.21873/anticanres.14282. Anticancer Res. 2020. PMID: 32487595 Review.
661 results